# Peptide Research: Studies in Plain English | PepVault

Source: https://pepvault.app/research

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[PepVault](https://pepvault.app/) Research

249 studies · 61 compounds

# Peptide research, one study at a time

Each page tells one published paper in plain words: what they tested, how, what they found with the paper’s own numbers, and what it doesn’t show. Every number is checked against the paper, and the paper is linked.

Checked November 2026

[How we research](https://pepvault.app/guides/how-we-research)

By compound

By kind

Healing & recovery

## BPC-157

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024) Clinical trial · people · 2024
- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021) Observational study · people · 2021
- [BPC-157 closed duodenocolic fistulas in rats](https://pepvault.app/research/bpc-157-vukusic-2024) Animal study · rats · 2024
- [BPC-157 restored cut muscle-tendon junctions in rats](https://pepvault.app/research/bpc-157-japjec-2021) Animal study · rats · 2021
- [BPC-157 countered succinylcholine hyperkalemia and arrhythmias in rats](https://pepvault.app/research/bpc-157-stambolija-2016) Animal study · rats · 2016

All 6 studies on BPC-157

- [BPC-157 sped tendon cell outgrowth and migration in rat cells](https://pepvault.app/research/bpc-157-chang-2011) Cell study · rat Achilles tendon fibroblasts · 2011

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=research-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

Healing & recovery

## TB-500

- [Thymosin beta-4 sped skin wound healing in diabetic and aged mice](https://pepvault.app/research/tb-500-philp-2003) Animal study · mice · 2003

Healing & recovery

## GHK-Cu

- [GHK-Cu gel: 98.5% median closure of diabetic plantar ulcers vs 60.8%](https://pepvault.app/research/ghk-cu-mulder-1994) Randomized trial · people · 1994
- [GHK-Cu eased lung inflammation and fibrosis in mice with silicosis](https://pepvault.app/research/ghk-cu-bian-2024) Animal study · mice · 2024
- [GHK-Cu liposomes sped scald wound healing in mice](https://pepvault.app/research/ghk-cu-wang-2017) Animal study · mice · 2017
- [GHK-Cu plus hyaluronic acid raised collagen IV in human fibroblasts](https://pepvault.app/research/ghk-cu-jiang-2023) Cell study · human dermal fibroblasts · 2023
- [GHK-Cu raised osteoblastic cell attachment in rat and human cells](https://pepvault.app/research/ghk-cu-godet-1995) Cell study · rat calvaria cells, human trabecular osteoblastic cells and human marrow stromal cells · 1995

All 6 studies on GHK-Cu

- [GHK-Cu boosted growth of chick embryo cartilage cells in culture](https://pepvault.app/research/ghk-cu-pesakova-1995) Cell study · chick embryo chondrocytes · 1995

## More on PepVault

### On PepVault

- [The peptide library](https://pepvault.app/peptides)
- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The glossary](https://pepvault.app/glossary)
- [Guides](https://pepvault.app/guides)
- [Free tools](https://pepvault.app/tools)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

### How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [About PepVault](https://pepvault.app/about)

Healing & recovery

## KPV

- [KPV in drinking water reduced colitis in 2 mouse models](https://pepvault.app/research/kpv-dalmasso-2008) Animal study · mice · 2008
- [KPV reduced white blood cell buildup in mice with peritonitis](https://pepvault.app/research/kpv-getting-2003) Animal study · mice · 2003

Healing & recovery

## AOD-9604

- [AOD-9604 knee injections lowered cartilage damage in rabbits](https://pepvault.app/research/aod-9604-kwon-2015) Animal study · rabbits · 2015
- [AOD-9604 lowered body weight and body fat in obese mice over 14 days](https://pepvault.app/research/aod-9604-heffernan-2001) Animal study · mice · 2001
- [AOD-9604 cut weight gain by over 50% in obese Zucker rats](https://pepvault.app/research/aod-9604-ng-2000) Animal study · obese Zucker rats · 2000
- [AOD-9604 reduced weight gain and fat tissue mass in obese mice](https://pepvault.app/research/aod-9604-natera-1994) Animal study · mice · 1994

Healing & recovery

## Thymosin Alpha-1

- [Thymosin Alpha-1 vs interferon in hepatitis B: better at follow-up](https://pepvault.app/research/thymosin-alpha-1-yang-2008) Meta-analysis · people · 2008
- [Thymosin alpha-1 lowered infections after colorectal cancer surgery](https://pepvault.app/research/thymosin-alpha-1-niu-2024) Randomized trial · people · 2024
- [Thymosin Alpha-1 combo: 30.0% pCR before gastric cancer surgery](https://pepvault.app/research/thymosin-alpha-1-xu-2026) Clinical trial · people · 2026

Healing & recovery

## Thymosin Beta-4

- [Thymosin beta-4: no overall infarct area cut in 96 STEMI patients](https://pepvault.app/research/thymosin-beta-4-zhang-2025) Randomized trial · people · 2025
- [Thymosin beta-4 in pregnant mice: longer newborns, more mature organs](https://pepvault.app/research/thymosin-beta-4-faa-2021) Animal study · mice · 2021
- [Thymosin beta-4 raised survival in mice with a coronavirus infection](https://pepvault.app/research/thymosin-beta-4-yu-2021) Animal study · mice · 2021
- [Thymosin beta-4: more liver fibrosis in mice bred to make extra TB4](https://pepvault.app/research/thymosin-beta-4-kim-2017) Animal study · mice · 2017
- [Thymosin Beta-4 sped full thickness skin wound healing in rats](https://pepvault.app/research/thymosin-beta-4-malinda-1999) Animal study · rats · 1999

All 7 studies on Thymosin Beta-4

- [Thymosin beta-4 rescued AD-linked defects in human brain organoids](https://pepvault.app/research/thymosin-beta-4-zeng-2025) Cell study · human brain organoids · 2025
- [Thymosin beta-4 cut prion-driven leak in human brain endothelial cells](https://pepvault.app/research/thymosin-beta-4-song-2020) Cell study · hCMEC/D3 human cerebral endothelial cells · 2020

Healing & recovery

## LL-37

- [LL-37 cream: bigger granulation gains in diabetic foot ulcers](https://pepvault.app/research/ll-37-miranda-2023) Randomized trial · people · 2023
- [LL-37: no healing gain over placebo for venous leg ulcers overall](https://pepvault.app/research/ll-37-heal-ll-37-2021) Randomized trial · people · 2021
- [LL-37 drove IL-1β and IL-18 release from human and murine macrophages](https://pepvault.app/research/ll-37-kahlenberg-2013) Cell study · human and murine macrophages · 2013
- [LL-37 raised TLR9 and interferon output in human skin cells](https://pepvault.app/research/ll-37-morizane-2012) Cell study · normal human keratinocytes · 2012

Healing & recovery

## Larazotide

- [Larazotide: eased GI symptoms in celiac patients on gluten challenge](https://pepvault.app/research/larazotide-hoilat-2022) Meta-analysis · people · 2022
- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007) Randomized trial · people · 2007

Healing & recovery

## VIP

- [VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19](https://pepvault.app/research/vip-esendagli-2025) Randomized trial · people · 2025
- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005) Clinical trial · people · 2005
- [VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol](https://pepvault.app/research/vip-morice-1986) Clinical trial · people · 1986
- [VIP: tear levels rose after laser eye surgery, peaking at 1 week](https://pepvault.app/research/vip-kang-2023) Observational study · people · 2023

Healing & recovery

## ARA-290

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017) Randomized trial · people · 2017
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013) Randomized trial · people · 2013
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012) Randomized trial · people · 2012
- [ARA-290 eased nerve-injury pain for up to 20 weeks in rats](https://pepvault.app/research/ara-290-swartjes-2014) Animal study · rats · 2014

Healing & recovery

## Ac-SDKP

- [Ac-SDKP: blood levels fell after kidney transplant in 14 patients](https://pepvault.app/research/tb-500-fragment-suzuki-2014) Clinical trial · people · 2014
- [Ac-SDKP taken by mouth eased kidney scarring in diabetic mice](https://pepvault.app/research/tb-500-fragment-nitta-2016) Animal study · mice · 2016

Growth hormone

## Ipamorelin

- [Ipamorelin reduced cisplatin weight loss by about 24% in ferrets](https://pepvault.app/research/ipamorelin-lu-2024) Animal study · ferrets · 2024
- [Ipamorelin sped gastric emptying after abdominal surgery in rats](https://pepvault.app/research/ipamorelin-greenwood-van-meerveld-2012) Animal study · rats · 2012
- [Ipamorelin sped first bowel movement after gut surgery in rats](https://pepvault.app/research/ipamorelin-venkova-2009) Animal study · rats · 2009
- [Ipamorelin for 21 days raised pituitary secretion granules in rats](https://pepvault.app/research/ipamorelin-jimenez-reina-2002) Animal study · rats · 2002
- [Ipamorelin offset glucocorticoid-linked bone formation drop in rats](https://pepvault.app/research/ipamorelin-andersen-2001) Animal study · rats · 2001

All 9 studies on ipamorelin

- [Ipamorelin raised bone mineral content in female rats over 12 weeks](https://pepvault.app/research/ipamorelin-svensson-2000) Animal study · rats · 2000
- [Ipamorelin: new derivative matched its GH potency in swine](https://pepvault.app/research/ipamorelin-ankersen-1998) Animal study · rats, swine and dogs · 1998
- [Ipamorelin: about 20% nasal bioavailability in rats](https://pepvault.app/research/ipamorelin-johansen-1998) Animal study · rats · 1998
- [Ipamorelin released GH without raising ACTH or cortisol in swine](https://pepvault.app/research/ipamorelin-raun-1998) Animal study · rats and swine · 1998

Growth hormone

## CJC-1295 with DAC

- [CJC-1295 with DAC: one shot raised GH 2- to 10-fold in healthy adults](https://pepvault.app/research/cjc-1295-with-dac-teichman-2006) Randomized trial · people · 2006
- [CJC-1295 with DAC changed serum protein patterns in healthy men](https://pepvault.app/research/cjc-1295-with-dac-sackmann-sala-2009) Clinical trial · people · 2009
- [CJC-1295 with DAC: trough GH up 7.5-fold, pulses kept in healthy men](https://pepvault.app/research/cjc-1295-with-dac-ionescu-2006) Clinical trial · people · 2006
- [CJC-1295 with DAC daily normalized growth in GHRH knockout mice](https://pepvault.app/research/cjc-1295-with-dac-alba-2006) Animal study · mice · 2006
- [CJC-1295 with DAC: 4-fold larger GH response than hGRF(1-29) in rats](https://pepvault.app/research/cjc-1295-with-dac-jette-2005) Animal study · rats · 2005

Growth hormone

## Tesamorelin

- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026) Meta-analysis · people · 2026
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020) Randomized trial · people · 2020
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019) Randomized trial · people · 2019
- [Tesamorelin: no change in glucose control in type 2 diabetes](https://pepvault.app/research/tesamorelin-clemmons-2017) Randomized trial · people · 2017
- [Tesamorelin cut visceral and liver fat over 6 months in HIV patients](https://pepvault.app/research/tesamorelin-stanley-2014) Randomized trial · people · 2014

All 12 studies on tesamorelin

- [Tesamorelin had little effect on simvastatin and ritonavir levels](https://pepvault.app/research/tesamorelin-teng-2013) Randomized trial · people · 2013
- [Tesamorelin cut visceral fat 15.4% vs placebo in HIV at 26 weeks](https://pepvault.app/research/tesamorelin-falutz-2010) Randomized trial · people · 2010
- [Tesamorelin: 10.9% less visceral fat at 6 months in HIV patients](https://pepvault.app/research/tesamorelin-falutz-2010-20101189) Randomized trial · people · 2010
- [Tesamorelin: visceral fat down 18% over 52 weeks in HIV patients](https://pepvault.app/research/tesamorelin-falutz-2008) Randomized trial · people · 2008
- [Tesamorelin: 15.2% drop in visceral fat at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-falutz-2007) Randomized trial · people · 2007
- [Tesamorelin drug levels unaffected by age, size, race or HIV status](https://pepvault.app/research/tesamorelin-gonzalez-sales-2015) Clinical trial · people · 2015
- [Tesamorelin: model accurately predicted GH and IGF-1 over 14 days](https://pepvault.app/research/tesamorelin-gonzalez-sales-2015-25895899) Clinical trial · people · 2015

Growth hormone

## GHRP-2

- [GHRP-2: 35.9% more food eaten at a buffet meal in healthy men](https://pepvault.app/research/ghrp-2-laferrere-2005) Clinical trial · people · 2005
- [GHRP-2: 30-day infusion raised GH and IGF-I in older adults](https://pepvault.app/research/ghrp-2-bowers-2004) Clinical trial · people · 2004
- [GHRP-2: stronger GH release than GHRH in 6 healthy young adults](https://pepvault.app/research/ghrp-2-arvat-1997) Clinical trial · people · 1997
- [GHRP-2: chronic dosing made GH response to GHRH combo synergistic](https://pepvault.app/research/ghrp-2-bowers-1996) Clinical trial · people · 1996

Growth hormone

## GHRP-6

- [GHRP-6 raised night GH, ACTH, cortisol and stage 2 sleep in men](https://pepvault.app/research/ghrp-6-frieboes-1995) Randomized trial · people · 1995
- [GHRP-6: weaker growth hormone release in thyrotoxicosis vs controls](https://pepvault.app/research/ghrp-6-nascif-2007) Clinical trial · people · 2007
- [GHRP-6 + GHRH: high blood sugar cut GH response in type 2 diabetes](https://pepvault.app/research/ghrp-6-micic-2004) Clinical trial · people · 2004

Growth hormone

## Hexarelin

- [Hexarelin: GH response fell over 16 weeks, recovered after a break](https://pepvault.app/research/hexarelin-rahim-1998) Clinical trial · people · 1998
- [Hexarelin protected rat hearts from ischemia-reperfusion damage](https://pepvault.app/research/hexarelin-locatelli-1999) Animal study · rats · 1999
- [Hexarelin kept its growth hormone effect over 60 days in old rats](https://pepvault.app/research/hexarelin-cattaneo-1997) Animal study · rats · 1997

Growth hormone

## MK-677

- [MK-677 raised IGF-1 but not most function after hip fracture](https://pepvault.app/research/mk-677-adunsky-2011) Randomized trial · people · 2011
- [MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 year](https://pepvault.app/research/mk-677-nass-2008) Randomized trial · people · 2008
- [MK-677 reversed diet-driven nitrogen loss in 8 healthy adults](https://pepvault.app/research/mk-677-murphy-1998) Randomized trial · people · 1998
- [MK-677: about 50% more stage IV sleep in young adults on 25 mg](https://pepvault.app/research/mk-677-copinschi-1997) Clinical trial · people · 1997

Growth hormone

## Fragment 176-191

- [Fragment 176-191 aided doxorubicin against MCF-7 breast cancer cells](https://pepvault.app/research/fragment-176-191-habibullah-2022) Cell study · human MCF-7 breast cancer cells · 2022

Growth hormone

## IGF-1 LR3

- [IGF-1 LR3 lowered blood sugar longer than native IGF-I in pigs](https://pepvault.app/research/igf-1-lr3-tomas-1997) Animal study · pigs and marmoset monkeys · 1997
- [IGF-1 LR3 raised organ weights but not growth in guinea pigs](https://pepvault.app/research/igf-1-lr3-conlon-1995) Animal study · guinea pigs · 1995
- [IGF-1 LR3: several times as potent as IGF-I for gut growth in rats](https://pepvault.app/research/igf-1-lr3-read-1992) Animal study · rats · 1992
- [IGF-1 LR3: about 2.5-fold more potent than IGF-I in catabolic rats](https://pepvault.app/research/igf-1-lr3-tomas-1992) Animal study · rats · 1992

Growth hormone

## PEG-MGF

- [PEG-MGF: heart function preserved after heart attack in mice](https://pepvault.app/research/peg-mgf-mavrommatis-2013) Animal study · mice · 2013
- [PEG-MGF (MGF): no rise in mouse or human muscle cell proliferation](https://pepvault.app/research/peg-mgf-fornaro-2014) Cell study · C2C12 cells, primary human skeletal muscle myoblasts, primary mouse skeletal muscle stem cells and cardiac myocytes · 2014
- [PEG-MGF extended division of human muscle cells from young donors](https://pepvault.app/research/peg-mgf-kandalla-2011) Cell study · human muscle cells · 2011

Growth hormone

## Follistatin-344

- [Follistatin-344 gene therapy: walk gains in some Becker patients](https://pepvault.app/research/follistatin-344-mendell-2015) Clinical trial · people · 2015
- [Follistatin-344: CSCR eye disorder in 11 bodybuilders after injection](https://pepvault.app/research/follistatin-344-dag-2020) Observational study · people · 2020

Metabolic & GLP-1

## Semaglutide

- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026) Randomized trial · people · 2026
- [Semaglutide: 36% vs 0% hit glucose and weight goal in type 1 diabetes](https://pepvault.app/research/semaglutide-adjust-t1d-2025) Randomized trial · people · 2025
- [Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4](https://pepvault.app/research/semaglutide-oasis-4-2025) Randomized trial · people · 2025
- [Semaglutide: MASH resolved in 62.9% vs 34.3% on placebo at 72 weeks](https://pepvault.app/research/semaglutide-sanyal-2025) Randomized trial · people · 2025
- [Semaglutide 7.2 mg: 18.7% weight loss at 72 weeks in STEP UP](https://pepvault.app/research/semaglutide-step-up-2025) Randomized trial · people · 2025

All 12 studies on semaglutide

- [Semaglutide: 24% lower risk of major kidney events in FLOW](https://pepvault.app/research/semaglutide-flow-2024) Randomized trial · people · 2024
- [Semaglutide pill: 15.1% weight loss at 68 weeks in OASIS 1](https://pepvault.app/research/semaglutide-oasis-1-2023) Randomized trial · people · 2023
- [Semaglutide: 6.5% vs 8.0% had a major heart event in SELECT](https://pepvault.app/research/semaglutide-select-2023) Randomized trial · people · 2023
- [Semaglutide: 35% lower lunch energy intake vs placebo at 20 weeks](https://pepvault.app/research/semaglutide-friedrichsen-2021) Randomized trial · people · 2021
- [Semaglutide: 14.9% weight loss at 68 weeks in STEP 1](https://pepvault.app/research/semaglutide-step-1-2021) Randomized trial · people · 2021
- [Semaglutide STEP 4: -7.9% weight vs +6.9% after switch to placebo](https://pepvault.app/research/semaglutide-step-4-2021) Randomized trial · people · 2021
- [Semaglutide: 6.6% vs 8.9% heart or stroke events in SUSTAIN-6](https://pepvault.app/research/semaglutide-sustain-6-2016) Randomized trial · people · 2016

Metabolic & GLP-1

## Semaglutide (oral)

- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026) Randomized trial · people · 2026
- [Semaglutide (oral): heart risk not higher than placebo in PIONEER 6](https://pepvault.app/research/semaglutide-oral-pioneer-6-2019) Randomized trial · people · 2019

Metabolic & GLP-1

## Tirzepatide

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026) Randomized trial · people · 2026
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238) Randomized trial · people · 2025
- [Tirzepatide: about 75% of weight lost was fat in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39996356) Randomized trial · people · 2025
- [Tirzepatide: most reached a weight plateau by week 72 in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-and-surmount-4-2025) Randomized trial · people · 2025
- [Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks](https://pepvault.app/research/tirzepatide-surmount-5-2025) Randomized trial · people · 2025

All 12 studies on tirzepatide

- [Tirzepatide: up to 17.5% weight loss at 52 weeks in SURMOUNT-CN](https://pepvault.app/research/tirzepatide-surmount-cn-2024) Randomized trial · people · 2024
- [Tirzepatide: AHI fell 25.3 and 29.3 events per hour in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2024) Randomized trial · people · 2024
- [Tirzepatide: 62% MASH resolution in 15 mg arm vs 10% on placebo](https://pepvault.app/research/tirzepatide-synergy-nash-2024) Randomized trial · people · 2024
- [Tirzepatide 15 mg: 14.7% weight loss at 72 weeks in SURMOUNT-2](https://pepvault.app/research/tirzepatide-surmount-2-2023) Randomized trial · people · 2023
- [Tirzepatide: HbA1c fell 2.1% vs 1.1% with insulin lispro in SURPASS-6](https://pepvault.app/research/tirzepatide-surpass-6-2023) Randomized trial · people · 2023
- [Tirzepatide: up to 20.9% weight loss at 72 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2022) Randomized trial · people · 2022
- [Tirzepatide: HbA1c fell up to 2.07% at 40 weeks in SURPASS-1](https://pepvault.app/research/tirzepatide-surpass-1-2021) Randomized trial · people · 2021

Metabolic & GLP-1

## Retatrutide

- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025) Meta-analysis · people · 2025
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026) Randomized trial · people · 2026
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) Randomized trial · people · 2026
- [Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes](https://pepvault.app/research/retatrutide-coskun-2025) Randomized trial · people · 2025
- [Retatrutide: up to 82.4% less liver fat at 24 weeks in MASLD trial](https://pepvault.app/research/retatrutide-sanyal-2024) Randomized trial · people · 2024

All 12 studies on retatrutide

- [Retatrutide: 24.2% weight loss at 48 weeks in the 12 mg arm](https://pepvault.app/research/retatrutide-jastreboff-2023) Randomized trial · people · 2023
- [Retatrutide: up to 8.96 kg placebo-adjusted weight loss in 12 weeks](https://pepvault.app/research/retatrutide-urva-2022) Randomized trial · people · 2022
- [Retatrutide lowered ANGPTL3/8 in step with triglycerides and LDL-C](https://pepvault.app/research/retatrutide-wen-2025) Clinical trial · people · 2025
- [Retatrutide cut body weight by 31% in obese mice with MASH](https://pepvault.app/research/retatrutide-briand-2026) Animal study · mice and hamsters · 2026
- [Retatrutide: 24.1% weight loss in MC4R-deficient mice over 21 days](https://pepvault.app/research/retatrutide-hitaka-2026) Animal study · mice · 2026
- [Retatrutide: 14-fold smaller pancreatic tumors in mice](https://pepvault.app/research/retatrutide-marathe-2025) Animal study · mice · 2025
- [Retatrutide eased diet-induced steatohepatitis in female mice](https://pepvault.app/research/retatrutide-viebahn-2025) Animal study · mice · 2025

Metabolic & GLP-1

## Liraglutide

- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022) Randomized trial · people · 2022
- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021) Randomized trial · people · 2021
- [Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER](https://pepvault.app/research/liraglutide-leader-2016) Randomized trial · people · 2016
- [Liraglutide: 8.4 kg lost vs 2.8 kg on placebo at 56 weeks](https://pepvault.app/research/liraglutide-scale-obesity-and-prediabetes-2015) Randomized trial · people · 2015

Metabolic & GLP-1

## Dulaglutide

- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025) Randomized trial · people · 2025
- [Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks](https://pepvault.app/research/dulaglutide-surpass-j-mono-2022) Randomized trial · people · 2022
- [Dulaglutide lowered major cardiovascular events (HR 0.88) in REWIND](https://pepvault.app/research/dulaglutide-rewind-2019) Randomized trial · people · 2019
- [Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7](https://pepvault.app/research/dulaglutide-sustain-7-2018) Randomized trial · people · 2018

Metabolic & GLP-1

## Orforglipron

- [Orforglipron: heart events no worse than insulin in ACHIEVE-4](https://pepvault.app/research/orforglipron-achieve-4-2026) Randomized trial · people · 2026
- [Orforglipron: 9.6% weight loss at 72 weeks in ATTAIN-2](https://pepvault.app/research/orforglipron-attain-2-2026) Randomized trial · people · 2026
- [Orforglipron 36 mg: 11.2% weight loss at 72 weeks in ATTAIN-1](https://pepvault.app/research/orforglipron-attain-1-2025) Randomized trial · people · 2025
- [Orforglipron: food lowered drug exposure by 17.6% to 23.7%](https://pepvault.app/research/orforglipron-ma-2024) Clinical trial · people · 2024

Metabolic & GLP-1

## Survodutide

- [Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026) Randomized trial · people · 2026
- [Survodutide: up to 14.9% weight loss at 46 weeks in phase 2 trial](https://pepvault.app/research/survodutide-le-roux-2024) Randomized trial · people · 2024

Metabolic & GLP-1

## Mazdutide

- [Mazdutide: 16.65% average weight loss at 60 weeks in GLORY-2](https://pepvault.app/research/mazdutide-glory-2-2026) Randomized trial · people · 2026
- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026) Randomized trial · people · 2026
- [Mazdutide: HbA1c fell 2.15% at 24 weeks in type 2 diabetes](https://pepvault.app/research/mazdutide-zhu-2026) Randomized trial · people · 2026
- [Mazdutide: 14.01% weight loss at 48 weeks in GLORY-1 (6 mg arm)](https://pepvault.app/research/mazdutide-glory-1-2025) Randomized trial · people · 2025

Metabolic & GLP-1

## Pemvidutide

- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026) Randomized trial · people · 2026
- [Pemvidutide: up to 76.4% liver fat reduction at 24 weeks in MASLD](https://pepvault.app/research/pemvidutide-browne-2025) Randomized trial · people · 2025
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025) Randomized trial · people · 2025
- [Pemvidutide cut body weight about 25% in mice with NASH](https://pepvault.app/research/pemvidutide-nestor-2022) Animal study · mice · 2022

Metabolic & GLP-1

## Cagrilintide

- [Cagrilintide with semaglutide: 17.1% weight loss at 2.4 mg, week 20](https://pepvault.app/research/cagrilintide-enebo-2021) Randomized trial · people · 2021

Metabolic & GLP-1

## CagriSema

- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026) Randomized trial · people · 2026

Metabolic & GLP-1

## 5-Amino-1MQ

- [5-Amino-1MQ slowed bladder tumor growth in mice](https://pepvault.app/research/5-amino-1mq-yang-2024) Animal study · mice · 2024
- [5-Amino-1MQ plus low-fat diet gave obese mice a distinct microbiome](https://pepvault.app/research/5-amino-1mq-dimet-wiley-2022) Animal study · mice · 2022
- [5-Amino-1MQ slowed growth of HeLa cervical cancer cells in the lab](https://pepvault.app/research/5-amino-1mq-akar-2021) Cell study · HeLa cervical cancer cells · 2021

Metabolic & GLP-1

## SLU-PP-332

- [SLU-PP-332 cut fat mass and improved insulin sensitivity in obese mice](https://pepvault.app/research/slu-pp-332-billon-2024) Animal study · mice · 2024
- [SLU-PP-332 improved ejection fraction and survival in mice](https://pepvault.app/research/slu-pp-332-xu-2024) Animal study · mice · 2024
- [SLU-PP-332 increased exercise endurance in mice](https://pepvault.app/research/slu-pp-332-billon-2023) Animal study · mice · 2023
- [SLU-PP-332 reversed age-related kidney changes in old mice](https://pepvault.app/research/slu-pp-332-wang-2023) Animal study · mice · 2023

Metabolic & GLP-1

## Oxytocin

- [Oxytocin: no gain over placebo on autism social measures at 24 weeks](https://pepvault.app/research/oxytocin-soars-b-2021) Randomized trial · people · 2021
- [Oxytocin nasal spray cut calories eaten at a breakfast test in men](https://pepvault.app/research/oxytocin-lawson-2015) Randomized trial · people · 2015
- [Oxytocin given in the nose raised trust in a controlled human trial](https://pepvault.app/research/oxytocin-kosfeld-2005) Clinical trial · people · 2005
- [Oxytocin in mice: 10ng/h raised anxiety; 1ng/h averted stress anxiety](https://pepvault.app/research/oxytocin-peters-2014) Animal study · mice · 2014

Longevity

## MOTS-c

- [MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivors](https://pepvault.app/research/mots-c-dieli-conwright-2021) Randomized trial · people · 2021
- [MOTS-c reduced islet cell senescence and glucose intolerance in mice](https://pepvault.app/research/mots-c-kong-2025) Animal study · mice · 2025
- [MOTS-c eased lung ischemia-reperfusion injury and deaths in rats](https://pepvault.app/research/mots-c-li-2025) Animal study · rats · 2025
- [MOTS-c improved heart mitochondrial respiration in diabetic rats](https://pepvault.app/research/mots-c-pham-2025) Animal study · rats · 2025
- [MOTS-c prevented muscle atrophy, raised muscle glucose uptake in mice](https://pepvault.app/research/mots-c-kumagai-2024) Animal study · mice · 2024

All 9 studies on MOTS-c

- [MOTS-c raised testosterone, LH and FSH in obese and non-obese rats](https://pepvault.app/research/mots-c-ozturk-ozturk-2024) Animal study · rats · 2024
- [MOTS-c improved heart small-vessel barrier under endotoxin in mice](https://pepvault.app/research/mots-c-zou-2024) Animal study · mice · 2024
- [MOTS-c eased high blood sugar in mice with gestational diabetes](https://pepvault.app/research/mots-c-yin-2022) Animal study · mice · 2022
- [MOTS-c lowered insulin, raised glucagon in pancreatic cell lines](https://pepvault.app/research/mots-c-bien-2024) Cell study · INS-1E and αTC-1 pancreatic cell lines · 2024

Longevity

## NAD+

- [NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 days](https://pepvault.app/research/nad-christen-2026) Randomized trial · people · 2026
- [NMN raised serum nicotinamide over 12 weeks in middle-aged adults](https://pepvault.app/research/nad-katayoshi-2023) Randomized trial · people · 2023
- [NMN raised muscle insulin sensitivity in women with prediabetes](https://pepvault.app/research/nad-yoshino-2021) Randomized trial · people · 2021
- [NAD+ rose with nicotinamide riboside in a 6-week crossover trial](https://pepvault.app/research/nad-martens-2018) Randomized trial · people · 2018

Longevity

## Glutathione

- [Glutathione: oral doses raised body glutathione stores over 6 months](https://pepvault.app/research/glutathione-richie-2015) Randomized trial · people · 2015
- [Glutathione: oral dose did not raise plasma levels in 7 adults](https://pepvault.app/research/glutathione-witschi-1992) Clinical trial · people · 1992
- [Glutathione IV: plasma level rose to 823 µmol/l, half-life 14.1 min](https://pepvault.app/research/glutathione-aebi-1991) Clinical trial · people · 1991

Longevity

## Epitalon

- [Epitalon: night melatonin rose in elderly with low pineal function](https://pepvault.app/research/epitalon-korkushko-2004) Randomized trial · people · 2004
- [Epitalon: positive clinical effect in 90% of retinal lesion cases](https://pepvault.app/research/epitalon-khavinson-2002) Clinical trial · people · 2002
- [Epitalon restored wound healing in high-glucose human retinal cells](https://pepvault.app/research/epitalon-gatta-2025) Cell study · human retinal pigment epithelial cells (ARPE-19) · 2025
- [Epitalon lowered ROS and apoptosis in aging mouse oocytes in vitro](https://pepvault.app/research/epitalon-yue-2022) Cell study · mouse oocytes · 2022

Longevity

## Humanin

- [Humanin: blood levels rise with age, highest in centenarians](https://pepvault.app/research/humanin-conte-2019) Observational study · people · 2019
- [Humanin inhibited IGFBP-3 cell death in human glioblastoma cells](https://pepvault.app/research/humanin-ikonen-2003) Cell study · human glioblastoma A172 cells and mouse cortical neurons · 2003

Longevity

## FOXO4-DRI

- [FOXO4-DRI improved sperm quality in naturally aged mice](https://pepvault.app/research/foxo4-dri-li-2024) Animal study · mice · 2024
- [FOXO4-DRI eased age-related testosterone shortfall in aged mice](https://pepvault.app/research/foxo4-dri-zhang-2020) Animal study · mice · 2020
- [FOXO4-DRI raised cell death in lab-grown keloid fibroblasts](https://pepvault.app/research/foxo4-dri-kong-2025) Cell study · human keloid fibroblasts · 2025
- [FOXO4-DRI cleared senescent cells from expanded human chondrocytes](https://pepvault.app/research/foxo4-dri-huang-2021) Cell study · human chondrocytes · 2021

Longevity

## SS-31

- [SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024) Randomized trial · people · 2024
- [SS-31: wearable data grouped responders with 100% accuracy](https://pepvault.app/research/ss-31-van-den-eynde-2023) Randomized trial · people · 2023
- [SS-31: no 12-week benefit, walk gains by 36 weeks open-label](https://pepvault.app/research/ss-31-reid-thompson-2021) Randomized trial · people · 2021
- [SS-31 raised muscle ATP capacity after one dose in older adults](https://pepvault.app/research/ss-31-roshanravan-2021) Randomized trial · people · 2021
- [SS-31: walk distance rose with dose in 5-day MMPOWER trial](https://pepvault.app/research/ss-31-mmpower-2018) Randomized trial · people · 2018

All 12 studies on SS-31

- [SS-31: less kidney hypoxia after renal artery stenting in pilot](https://pepvault.app/research/ss-31-saad-2017) Randomized trial · people · 2017
- [SS-31 did not significantly cut infarct size in EMBRACE STEMI](https://pepvault.app/research/ss-31-embrace-stemi-2016) Randomized trial · people · 2016
- [SS-31 (elamipretide) lowered blood HtrA2 after STEMI heart attack](https://pepvault.app/research/ss-31-embrace-2019) Clinical trial · people · 2019
- [SS-31: 79.7 m better walk test vs untreated in Barth syndrome](https://pepvault.app/research/ss-31-tazpower-2022) Observational study · people · 2022
- [SS-31 aided functional recovery after spinal cord injury in mice](https://pepvault.app/research/ss-31-zhang-2023) Animal study · mice · 2023
- [SS-31 partly undid age-related muscle phosphorylation in old mice](https://pepvault.app/research/ss-31-campbell-2022) Animal study · mice · 2022
- [SS-31 eased LPS-induced learning and memory problems in mice](https://pepvault.app/research/ss-31-zhao-2019) Animal study · mice · 2019

Longevity

## Pinealon

- [Pinealon improved learning in offspring of rats fed extra methionine](https://pepvault.app/research/pinealon-arutjunyan-2012) Animal study · rats · 2012
- [Pinealon lowered free radicals and cell death in PC12 and brain cells](https://pepvault.app/research/pinealon-khavinson-2011) Cell study · cerebellar granule cells, neutrophils and PC12 cells · 2011

Longevity

## Vesugen

- [Vesugen (KED) prevented dendritic spine loss in Alzheimer's mice](https://pepvault.app/research/vesugen-khavinson-2021) Animal study · mice · 2021

Longevity

## Klotho

- [Klotho: higher genetic levels tied to lower atrial fibrillation risk](https://pepvault.app/research/klotho-sun-2022) Meta-analysis · people · 2022
- [Klotho: one low dose enhanced memory in aged nonhuman primates](https://pepvault.app/research/klotho-castner-2023) Animal study · aged nonhuman primates · 2023
- [Klotho: higher levels improved learning and memory in mice](https://pepvault.app/research/klotho-dubal-2014) Animal study · mice · 2014

Longevity

## NMN

- [NMN: no significant benefit on blood sugar or lipids in pooled trials](https://pepvault.app/research/nmn-chen-2024) Meta-analysis · people · 2024
- [NMN: raised blood NAD over 60 days in 80 middle-aged adults](https://pepvault.app/research/nmn-yi-2023) Randomized trial · people · 2023
- [NMN supplements raised blood NAD+ levels in healthy older men](https://pepvault.app/research/nmn-igarashi-2022) Randomized trial · people · 2022
- [NMN: aerobic gains at 600 and 1200 mg/day in amateur runners](https://pepvault.app/research/nmn-liao-2021) Randomized trial · people · 2021

Longevity

## DSIP

- [DSIP: longer, less interrupted sleep in 6 people with chronic insomnia](https://pepvault.app/research/dsip-schneider-helmert-1981) Clinical trial · people · 1981

Cognitive

## Dihexa

- [Dihexa plus stem cells improved rat motor function after nerve repair](https://pepvault.app/research/dihexa-weiss-2021) Animal study · rats · 2021
- [Dihexa showed antidementia activity in scopolamine and aged rat models](https://pepvault.app/research/dihexa-mccoy-2013) Animal study · rats · 2013

Cognitive

## Selank

- [Selank and GABA changed expression of 45 rat brain genes at 1 hour](https://pepvault.app/research/selank-volkova-2016) Animal study · rats · 2016

Cognitive

## Semax

- [Semax shifted BDNF and NGF gene activity in rat brain within 1 hour](https://pepvault.app/research/semax-agapova-2007) Animal study · rats · 2007
- [Semax raised hippocampal BDNF levels up to 1.4-fold in rats](https://pepvault.app/research/semax-dolotov-2006) Animal study · rats · 2006
- [Semax raised striatal 5-HIAA to 180% in rodents](https://pepvault.app/research/semax-eremin-2005) Animal study · rodents · 2005

Cognitive

## NSI-189

- [NSI-189 80 mg beat placebo in moderate, not severe, depression](https://pepvault.app/research/nsi-189-johe-2020) Randomized trial · people · 2020
- [NSI-189 eased nerve damage and memory problems in diabetic rats](https://pepvault.app/research/nsi-189-jolivalt-2022) Animal study · rats · 2022
- [NSI-189 protected nerves and memory in diabetic mice](https://pepvault.app/research/nsi-189-jolivalt-2019) Animal study · mice · 2019
- [NSI-189 eased motor and neurological deficits after stroke in rats](https://pepvault.app/research/nsi-189-tajiri-2017) Animal study · rats · 2017

Cognitive

## P21

- [P21: lowered tau in the brain and spinal fluid of aged rats](https://pepvault.app/research/p21-khatoon-2015) Animal study · rats · 2015
- [P21 reduced tau buildup and cognitive deficits in Alzheimer's mice](https://pepvault.app/research/p21-kazim-2014) Animal study · mice · 2014

Cognitive

## Cerebrolysin

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018) Meta-analysis · people · 2018
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015) Meta-analysis · people · 2015
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016) Randomized trial · people · 2016
- [Cerebrolysin: no overall benefit in acute ischemic stroke at 90 days](https://pepvault.app/research/cerebrolysin-heiss-2012) Randomized trial · people · 2012

Sexual health

## PT-141

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021) Meta-analysis · people · 2021
- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016) Randomized trial · people · 2016
- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022) Systematic review · people · 2022

Sexual health

## Kisspeptin-10

- [Kisspeptin-10: daily 8 h infusions kept LH raised for 12 days in men](https://pepvault.app/research/kisspeptin-10-yeung-2026) Randomized trial · people · 2026
- [Kisspeptin-10 raised osteocalcin by up to 20.3% in healthy men](https://pepvault.app/research/kisspeptin-10-comninos-2022) Randomized trial · people · 2022

Sexual health

## Enclomiphene

- [Enclomiphene or clomiphene raised testosterone vs placebo in men](https://pepvault.app/research/enclomiphene-hohl-2025) Meta-analysis · people · 2025
- [Enclomiphene raised testosterone, kept sperm counts normal vs gel](https://pepvault.app/research/enclomiphene-za-304-and-za-305-2016) Randomized trial · people · 2016
- [Enclomiphene raised testosterone like gel and also raised sperm counts](https://pepvault.app/research/enclomiphene-kaminetsky-2013) Randomized trial · people · 2013
- [Enclomiphene 25 mg: testosterone 604 ng/dL by Day 42, similar to gel](https://pepvault.app/research/enclomiphene-wiehle-2013) Randomized trial · people · 2013

Sexual health

## Melanotan II

- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000) Clinical trial · people · 2000
- [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998) Clinical trial · people · 1998
- [Melanotan II: darker skin in 2 of 3 men in a small phase I trial](https://pepvault.app/research/melanotan-ii-dorr-1996) Clinical trial · people · 1996
- [Melanotan II: melanoma diagnosed in a 20-year-old woman after use](https://pepvault.app/research/melanotan-ii-hjuler-2014) Observational study · people · 2014

Sexual health

## Melanotan I

- [Melanotan I: more pain-free sun time in protoporphyria trials](https://pepvault.app/research/melanotan-i-langendonk-2015) Randomized trial · people · 2015
- [Melanotan I plus UV-B: 48.64% vitiligo repigmentation at day 168](https://pepvault.app/research/melanotan-i-lim-2015) Randomized trial · people · 2015
- [Melanotan I: well tolerated in 6 acute stroke patients](https://pepvault.app/research/melanotan-i-stanislaus-2023) Clinical trial · people · 2023

By kind

## Meta-analysis

- [Thymosin Alpha-1 vs interferon in hepatitis B: better at follow-up](https://pepvault.app/research/thymosin-alpha-1-yang-2008) Meta-analysis · people · 2008
- [Larazotide: eased GI symptoms in celiac patients on gluten challenge](https://pepvault.app/research/larazotide-hoilat-2022) Meta-analysis · people · 2022
- [Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy](https://pepvault.app/research/tesamorelin-badran-2026) Meta-analysis · people · 2026
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025) Meta-analysis · people · 2025
- [Klotho: higher genetic levels tied to lower atrial fibrillation risk](https://pepvault.app/research/klotho-sun-2022) Meta-analysis · people · 2022
- [NMN: no significant benefit on blood sugar or lipids in pooled trials](https://pepvault.app/research/nmn-chen-2024) Meta-analysis · people · 2024
- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018) Meta-analysis · people · 2018
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015) Meta-analysis · people · 2015
- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021) Meta-analysis · people · 2021
- [Enclomiphene or clomiphene raised testosterone vs placebo in men](https://pepvault.app/research/enclomiphene-hohl-2025) Meta-analysis · people · 2025

By kind

## Randomized trial

- [GHK-Cu gel: 98.5% median closure of diabetic plantar ulcers vs 60.8%](https://pepvault.app/research/ghk-cu-mulder-1994) Randomized trial · people · 1994
- [Thymosin alpha-1 lowered infections after colorectal cancer surgery](https://pepvault.app/research/thymosin-alpha-1-niu-2024) Randomized trial · people · 2024
- [Thymosin beta-4: no overall infarct area cut in 96 STEMI patients](https://pepvault.app/research/thymosin-beta-4-zhang-2025) Randomized trial · people · 2025
- [LL-37 cream: bigger granulation gains in diabetic foot ulcers](https://pepvault.app/research/ll-37-miranda-2023) Randomized trial · people · 2023
- [LL-37: no healing gain over placebo for venous leg ulcers overall](https://pepvault.app/research/ll-37-heal-ll-37-2021) Randomized trial · people · 2021
- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007) Randomized trial · people · 2007
- [VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19](https://pepvault.app/research/vip-esendagli-2025) Randomized trial · people · 2025
- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017) Randomized trial · people · 2017
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013) Randomized trial · people · 2013
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012) Randomized trial · people · 2012
- [CJC-1295 with DAC: one shot raised GH 2- to 10-fold in healthy adults](https://pepvault.app/research/cjc-1295-with-dac-teichman-2006) Randomized trial · people · 2006
- [Tesamorelin shifted liver gene activity in HIV-related fatty liver](https://pepvault.app/research/tesamorelin-fourman-2020) Randomized trial · people · 2020
- [Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-adrian-2019) Randomized trial · people · 2019
- [Tesamorelin: no change in glucose control in type 2 diabetes](https://pepvault.app/research/tesamorelin-clemmons-2017) Randomized trial · people · 2017
- [Tesamorelin cut visceral and liver fat over 6 months in HIV patients](https://pepvault.app/research/tesamorelin-stanley-2014) Randomized trial · people · 2014
- [Tesamorelin had little effect on simvastatin and ritonavir levels](https://pepvault.app/research/tesamorelin-teng-2013) Randomized trial · people · 2013
- [Tesamorelin cut visceral fat 15.4% vs placebo in HIV at 26 weeks](https://pepvault.app/research/tesamorelin-falutz-2010) Randomized trial · people · 2010
- [Tesamorelin: 10.9% less visceral fat at 6 months in HIV patients](https://pepvault.app/research/tesamorelin-falutz-2010-20101189) Randomized trial · people · 2010
- [Tesamorelin: visceral fat down 18% over 52 weeks in HIV patients](https://pepvault.app/research/tesamorelin-falutz-2008) Randomized trial · people · 2008
- [Tesamorelin: 15.2% drop in visceral fat at 26 weeks in HIV](https://pepvault.app/research/tesamorelin-falutz-2007) Randomized trial · people · 2007
- [GHRP-6 raised night GH, ACTH, cortisol and stage 2 sleep in men](https://pepvault.app/research/ghrp-6-frieboes-1995) Randomized trial · people · 1995
- [MK-677 raised IGF-1 but not most function after hip fracture](https://pepvault.app/research/mk-677-adunsky-2011) Randomized trial · people · 2011
- [MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 year](https://pepvault.app/research/mk-677-nass-2008) Randomized trial · people · 2008
- [MK-677 reversed diet-driven nitrogen loss in 8 healthy adults](https://pepvault.app/research/mk-677-murphy-1998) Randomized trial · people · 1998
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026) Randomized trial · people · 2026
- [Semaglutide: 36% vs 0% hit glucose and weight goal in type 1 diabetes](https://pepvault.app/research/semaglutide-adjust-t1d-2025) Randomized trial · people · 2025
- [Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4](https://pepvault.app/research/semaglutide-oasis-4-2025) Randomized trial · people · 2025
- [Semaglutide: MASH resolved in 62.9% vs 34.3% on placebo at 72 weeks](https://pepvault.app/research/semaglutide-sanyal-2025) Randomized trial · people · 2025
- [Semaglutide 7.2 mg: 18.7% weight loss at 72 weeks in STEP UP](https://pepvault.app/research/semaglutide-step-up-2025) Randomized trial · people · 2025
- [Semaglutide: 24% lower risk of major kidney events in FLOW](https://pepvault.app/research/semaglutide-flow-2024) Randomized trial · people · 2024
- [Semaglutide pill: 15.1% weight loss at 68 weeks in OASIS 1](https://pepvault.app/research/semaglutide-oasis-1-2023) Randomized trial · people · 2023
- [Semaglutide: 6.5% vs 8.0% had a major heart event in SELECT](https://pepvault.app/research/semaglutide-select-2023) Randomized trial · people · 2023
- [Semaglutide: 35% lower lunch energy intake vs placebo at 20 weeks](https://pepvault.app/research/semaglutide-friedrichsen-2021) Randomized trial · people · 2021
- [Semaglutide: 14.9% weight loss at 68 weeks in STEP 1](https://pepvault.app/research/semaglutide-step-1-2021) Randomized trial · people · 2021
- [Semaglutide STEP 4: -7.9% weight vs +6.9% after switch to placebo](https://pepvault.app/research/semaglutide-step-4-2021) Randomized trial · people · 2021
- [Semaglutide: 6.6% vs 8.9% heart or stroke events in SUSTAIN-6](https://pepvault.app/research/semaglutide-sustain-6-2016) Randomized trial · people · 2016
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026) Randomized trial · people · 2026
- [Semaglutide (oral): heart risk not higher than placebo in PIONEER 6](https://pepvault.app/research/semaglutide-oral-pioneer-6-2019) Randomized trial · people · 2019
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026) Randomized trial · people · 2026
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238) Randomized trial · people · 2025
- [Tirzepatide: about 75% of weight lost was fat in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39996356) Randomized trial · people · 2025
- [Tirzepatide: most reached a weight plateau by week 72 in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-and-surmount-4-2025) Randomized trial · people · 2025
- [Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks](https://pepvault.app/research/tirzepatide-surmount-5-2025) Randomized trial · people · 2025
- [Tirzepatide: up to 17.5% weight loss at 52 weeks in SURMOUNT-CN](https://pepvault.app/research/tirzepatide-surmount-cn-2024) Randomized trial · people · 2024
- [Tirzepatide: AHI fell 25.3 and 29.3 events per hour in SURMOUNT-OSA](https://pepvault.app/research/tirzepatide-surmount-osa-2024) Randomized trial · people · 2024
- [Tirzepatide: 62% MASH resolution in 15 mg arm vs 10% on placebo](https://pepvault.app/research/tirzepatide-synergy-nash-2024) Randomized trial · people · 2024
- [Tirzepatide 15 mg: 14.7% weight loss at 72 weeks in SURMOUNT-2](https://pepvault.app/research/tirzepatide-surmount-2-2023) Randomized trial · people · 2023
- [Tirzepatide: HbA1c fell 2.1% vs 1.1% with insulin lispro in SURPASS-6](https://pepvault.app/research/tirzepatide-surpass-6-2023) Randomized trial · people · 2023
- [Tirzepatide: up to 20.9% weight loss at 72 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2022) Randomized trial · people · 2022
- [Tirzepatide: HbA1c fell up to 2.07% at 40 weeks in SURPASS-1](https://pepvault.app/research/tirzepatide-surpass-1-2021) Randomized trial · people · 2021
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026) Randomized trial · people · 2026
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) Randomized trial · people · 2026
- [Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes](https://pepvault.app/research/retatrutide-coskun-2025) Randomized trial · people · 2025
- [Retatrutide: up to 82.4% less liver fat at 24 weeks in MASLD trial](https://pepvault.app/research/retatrutide-sanyal-2024) Randomized trial · people · 2024
- [Retatrutide: 24.2% weight loss at 48 weeks in the 12 mg arm](https://pepvault.app/research/retatrutide-jastreboff-2023) Randomized trial · people · 2023
- [Retatrutide: up to 8.96 kg placebo-adjusted weight loss in 12 weeks](https://pepvault.app/research/retatrutide-urva-2022) Randomized trial · people · 2022
- [Liraglutide: 6.4% weight loss vs 15.8% on semaglutide in STEP 8](https://pepvault.app/research/liraglutide-step-8-2022) Randomized trial · people · 2022
- [Liraglutide plus exercise: 9.5 kg more loss than placebo at 1 year](https://pepvault.app/research/liraglutide-lundgren-2021) Randomized trial · people · 2021
- [Liraglutide: 13.0% vs 14.9% major cardiovascular events in LEADER](https://pepvault.app/research/liraglutide-leader-2016) Randomized trial · people · 2016
- [Liraglutide: 8.4 kg lost vs 2.8 kg on placebo at 56 weeks](https://pepvault.app/research/liraglutide-scale-obesity-and-prediabetes-2015) Randomized trial · people · 2015
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025) Randomized trial · people · 2025
- [Dulaglutide cut HbA1c 1.3 vs 2.4 to 2.8 with tirzepatide at 52 weeks](https://pepvault.app/research/dulaglutide-surpass-j-mono-2022) Randomized trial · people · 2022
- [Dulaglutide lowered major cardiovascular events (HR 0.88) in REWIND](https://pepvault.app/research/dulaglutide-rewind-2019) Randomized trial · people · 2019
- [Dulaglutide cut HbA1c and weight less than semaglutide in SUSTAIN 7](https://pepvault.app/research/dulaglutide-sustain-7-2018) Randomized trial · people · 2018
- [Orforglipron: heart events no worse than insulin in ACHIEVE-4](https://pepvault.app/research/orforglipron-achieve-4-2026) Randomized trial · people · 2026
- [Orforglipron: 9.6% weight loss at 72 weeks in ATTAIN-2](https://pepvault.app/research/orforglipron-attain-2-2026) Randomized trial · people · 2026
- [Orforglipron 36 mg: 11.2% weight loss at 72 weeks in ATTAIN-1](https://pepvault.app/research/orforglipron-attain-1-2025) Randomized trial · people · 2025
- [Survodutide: 12.2% weight loss and less liver fat at 48 weeks](https://pepvault.app/research/survodutide-synchronize-masld-2026) Randomized trial · people · 2026
- [Survodutide: up to 14.9% weight loss at 46 weeks in phase 2 trial](https://pepvault.app/research/survodutide-le-roux-2024) Randomized trial · people · 2024
- [Mazdutide: 16.65% average weight loss at 60 weeks in GLORY-2](https://pepvault.app/research/mazdutide-glory-2-2026) Randomized trial · people · 2026
- [Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks](https://pepvault.app/research/mazdutide-guo-2026) Randomized trial · people · 2026
- [Mazdutide: HbA1c fell 2.15% at 24 weeks in type 2 diabetes](https://pepvault.app/research/mazdutide-zhu-2026) Randomized trial · people · 2026
- [Mazdutide: 14.01% weight loss at 48 weeks in GLORY-1 (6 mg arm)](https://pepvault.app/research/mazdutide-glory-1-2025) Randomized trial · people · 2025
- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026) Randomized trial · people · 2026
- [Pemvidutide: up to 76.4% liver fat reduction at 24 weeks in MASLD](https://pepvault.app/research/pemvidutide-browne-2025) Randomized trial · people · 2025
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025) Randomized trial · people · 2025
- [Cagrilintide with semaglutide: 17.1% weight loss at 2.4 mg, week 20](https://pepvault.app/research/cagrilintide-enebo-2021) Randomized trial · people · 2021
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026) Randomized trial · people · 2026
- [Oxytocin: no gain over placebo on autism social measures at 24 weeks](https://pepvault.app/research/oxytocin-soars-b-2021) Randomized trial · people · 2021
- [Oxytocin nasal spray cut calories eaten at a breakfast test in men](https://pepvault.app/research/oxytocin-lawson-2015) Randomized trial · people · 2015
- [MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivors](https://pepvault.app/research/mots-c-dieli-conwright-2021) Randomized trial · people · 2021
- [NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 days](https://pepvault.app/research/nad-christen-2026) Randomized trial · people · 2026
- [NMN raised serum nicotinamide over 12 weeks in middle-aged adults](https://pepvault.app/research/nad-katayoshi-2023) Randomized trial · people · 2023
- [NMN raised muscle insulin sensitivity in women with prediabetes](https://pepvault.app/research/nad-yoshino-2021) Randomized trial · people · 2021
- [NAD+ rose with nicotinamide riboside in a 6-week crossover trial](https://pepvault.app/research/nad-martens-2018) Randomized trial · people · 2018
- [Glutathione: oral doses raised body glutathione stores over 6 months](https://pepvault.app/research/glutathione-richie-2015) Randomized trial · people · 2015
- [Epitalon: night melatonin rose in elderly with low pineal function](https://pepvault.app/research/epitalon-korkushko-2004) Randomized trial · people · 2004
- [SS-31 (elamipretide) eye drops missed main vision goal in LHON trial](https://pepvault.app/research/ss-31-karanjia-2024) Randomized trial · people · 2024
- [SS-31: wearable data grouped responders with 100% accuracy](https://pepvault.app/research/ss-31-van-den-eynde-2023) Randomized trial · people · 2023
- [SS-31: no 12-week benefit, walk gains by 36 weeks open-label](https://pepvault.app/research/ss-31-reid-thompson-2021) Randomized trial · people · 2021
- [SS-31 raised muscle ATP capacity after one dose in older adults](https://pepvault.app/research/ss-31-roshanravan-2021) Randomized trial · people · 2021
- [SS-31: walk distance rose with dose in 5-day MMPOWER trial](https://pepvault.app/research/ss-31-mmpower-2018) Randomized trial · people · 2018
- [SS-31: less kidney hypoxia after renal artery stenting in pilot](https://pepvault.app/research/ss-31-saad-2017) Randomized trial · people · 2017
- [SS-31 did not significantly cut infarct size in EMBRACE STEMI](https://pepvault.app/research/ss-31-embrace-stemi-2016) Randomized trial · people · 2016
- [NMN: raised blood NAD over 60 days in 80 middle-aged adults](https://pepvault.app/research/nmn-yi-2023) Randomized trial · people · 2023
- [NMN supplements raised blood NAD+ levels in healthy older men](https://pepvault.app/research/nmn-igarashi-2022) Randomized trial · people · 2022
- [NMN: aerobic gains at 600 and 1200 mg/day in amateur runners](https://pepvault.app/research/nmn-liao-2021) Randomized trial · people · 2021
- [NSI-189 80 mg beat placebo in moderate, not severe, depression](https://pepvault.app/research/nsi-189-johe-2020) Randomized trial · people · 2020
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016) Randomized trial · people · 2016
- [Cerebrolysin: no overall benefit in acute ischemic stroke at 90 days](https://pepvault.app/research/cerebrolysin-heiss-2012) Randomized trial · people · 2012
- [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016) Randomized trial · people · 2016
- [Kisspeptin-10: daily 8 h infusions kept LH raised for 12 days in men](https://pepvault.app/research/kisspeptin-10-yeung-2026) Randomized trial · people · 2026
- [Kisspeptin-10 raised osteocalcin by up to 20.3% in healthy men](https://pepvault.app/research/kisspeptin-10-comninos-2022) Randomized trial · people · 2022
- [Enclomiphene raised testosterone, kept sperm counts normal vs gel](https://pepvault.app/research/enclomiphene-za-304-and-za-305-2016) Randomized trial · people · 2016
- [Enclomiphene raised testosterone like gel and also raised sperm counts](https://pepvault.app/research/enclomiphene-kaminetsky-2013) Randomized trial · people · 2013
- [Enclomiphene 25 mg: testosterone 604 ng/dL by Day 42, similar to gel](https://pepvault.app/research/enclomiphene-wiehle-2013) Randomized trial · people · 2013
- [Melanotan I: more pain-free sun time in protoporphyria trials](https://pepvault.app/research/melanotan-i-langendonk-2015) Randomized trial · people · 2015
- [Melanotan I plus UV-B: 48.64% vitiligo repigmentation at day 168](https://pepvault.app/research/melanotan-i-lim-2015) Randomized trial · people · 2015

By kind

## Clinical trial

- [BPC-157: 10 of 12 women reported full interstitial cystitis relief](https://pepvault.app/research/bpc-157-lee-2024) Clinical trial · people · 2024
- [Thymosin Alpha-1 combo: 30.0% pCR before gastric cancer surgery](https://pepvault.app/research/thymosin-alpha-1-xu-2026) Clinical trial · people · 2026
- [VIP fragment VIP10-28 boosted, not blocked, skin vessel widening](https://pepvault.app/research/vip-wilkins-2005) Clinical trial · people · 2005
- [VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol](https://pepvault.app/research/vip-morice-1986) Clinical trial · people · 1986
- [Ac-SDKP: blood levels fell after kidney transplant in 14 patients](https://pepvault.app/research/tb-500-fragment-suzuki-2014) Clinical trial · people · 2014
- [CJC-1295 with DAC changed serum protein patterns in healthy men](https://pepvault.app/research/cjc-1295-with-dac-sackmann-sala-2009) Clinical trial · people · 2009
- [CJC-1295 with DAC: trough GH up 7.5-fold, pulses kept in healthy men](https://pepvault.app/research/cjc-1295-with-dac-ionescu-2006) Clinical trial · people · 2006
- [Tesamorelin drug levels unaffected by age, size, race or HIV status](https://pepvault.app/research/tesamorelin-gonzalez-sales-2015) Clinical trial · people · 2015
- [Tesamorelin: model accurately predicted GH and IGF-1 over 14 days](https://pepvault.app/research/tesamorelin-gonzalez-sales-2015-25895899) Clinical trial · people · 2015
- [GHRP-2: 35.9% more food eaten at a buffet meal in healthy men](https://pepvault.app/research/ghrp-2-laferrere-2005) Clinical trial · people · 2005
- [GHRP-2: 30-day infusion raised GH and IGF-I in older adults](https://pepvault.app/research/ghrp-2-bowers-2004) Clinical trial · people · 2004
- [GHRP-2: stronger GH release than GHRH in 6 healthy young adults](https://pepvault.app/research/ghrp-2-arvat-1997) Clinical trial · people · 1997
- [GHRP-2: chronic dosing made GH response to GHRH combo synergistic](https://pepvault.app/research/ghrp-2-bowers-1996) Clinical trial · people · 1996
- [GHRP-6: weaker growth hormone release in thyrotoxicosis vs controls](https://pepvault.app/research/ghrp-6-nascif-2007) Clinical trial · people · 2007
- [GHRP-6 + GHRH: high blood sugar cut GH response in type 2 diabetes](https://pepvault.app/research/ghrp-6-micic-2004) Clinical trial · people · 2004
- [Hexarelin: GH response fell over 16 weeks, recovered after a break](https://pepvault.app/research/hexarelin-rahim-1998) Clinical trial · people · 1998
- [MK-677: about 50% more stage IV sleep in young adults on 25 mg](https://pepvault.app/research/mk-677-copinschi-1997) Clinical trial · people · 1997
- [Follistatin-344 gene therapy: walk gains in some Becker patients](https://pepvault.app/research/follistatin-344-mendell-2015) Clinical trial · people · 2015
- [Retatrutide lowered ANGPTL3/8 in step with triglycerides and LDL-C](https://pepvault.app/research/retatrutide-wen-2025) Clinical trial · people · 2025
- [Orforglipron: food lowered drug exposure by 17.6% to 23.7%](https://pepvault.app/research/orforglipron-ma-2024) Clinical trial · people · 2024
- [Oxytocin given in the nose raised trust in a controlled human trial](https://pepvault.app/research/oxytocin-kosfeld-2005) Clinical trial · people · 2005
- [Glutathione: oral dose did not raise plasma levels in 7 adults](https://pepvault.app/research/glutathione-witschi-1992) Clinical trial · people · 1992
- [Glutathione IV: plasma level rose to 823 µmol/l, half-life 14.1 min](https://pepvault.app/research/glutathione-aebi-1991) Clinical trial · people · 1991
- [Epitalon: positive clinical effect in 90% of retinal lesion cases](https://pepvault.app/research/epitalon-khavinson-2002) Clinical trial · people · 2002
- [SS-31 (elamipretide) lowered blood HtrA2 after STEMI heart attack](https://pepvault.app/research/ss-31-embrace-2019) Clinical trial · people · 2019
- [DSIP: longer, less interrupted sleep in 6 people with chronic insomnia](https://pepvault.app/research/dsip-schneider-helmert-1981) Clinical trial · people · 1981
- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000) Clinical trial · people · 2000
- [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998) Clinical trial · people · 1998
- [Melanotan II: darker skin in 2 of 3 men in a small phase I trial](https://pepvault.app/research/melanotan-ii-dorr-1996) Clinical trial · people · 1996
- [Melanotan I: well tolerated in 6 acute stroke patients](https://pepvault.app/research/melanotan-i-stanislaus-2023) Clinical trial · people · 2023

By kind

## Observational study

- [BPC-157: 14 of 16 reported knee pain relief in a chart review](https://pepvault.app/research/bpc-157-lee-2021) Observational study · people · 2021
- [VIP: tear levels rose after laser eye surgery, peaking at 1 week](https://pepvault.app/research/vip-kang-2023) Observational study · people · 2023
- [Follistatin-344: CSCR eye disorder in 11 bodybuilders after injection](https://pepvault.app/research/follistatin-344-dag-2020) Observational study · people · 2020
- [Humanin: blood levels rise with age, highest in centenarians](https://pepvault.app/research/humanin-conte-2019) Observational study · people · 2019
- [SS-31: 79.7 m better walk test vs untreated in Barth syndrome](https://pepvault.app/research/ss-31-tazpower-2022) Observational study · people · 2022
- [Melanotan II: melanoma diagnosed in a 20-year-old woman after use](https://pepvault.app/research/melanotan-ii-hjuler-2014) Observational study · people · 2014

By kind

## Systematic review

- [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022) Systematic review · people · 2022

By kind

## Animal study

- [BPC-157 closed duodenocolic fistulas in rats](https://pepvault.app/research/bpc-157-vukusic-2024) Animal study · rats · 2024
- [BPC-157 restored cut muscle-tendon junctions in rats](https://pepvault.app/research/bpc-157-japjec-2021) Animal study · rats · 2021
- [BPC-157 countered succinylcholine hyperkalemia and arrhythmias in rats](https://pepvault.app/research/bpc-157-stambolija-2016) Animal study · rats · 2016
- [Thymosin beta-4 sped skin wound healing in diabetic and aged mice](https://pepvault.app/research/tb-500-philp-2003) Animal study · mice · 2003
- [GHK-Cu eased lung inflammation and fibrosis in mice with silicosis](https://pepvault.app/research/ghk-cu-bian-2024) Animal study · mice · 2024
- [GHK-Cu liposomes sped scald wound healing in mice](https://pepvault.app/research/ghk-cu-wang-2017) Animal study · mice · 2017
- [KPV in drinking water reduced colitis in 2 mouse models](https://pepvault.app/research/kpv-dalmasso-2008) Animal study · mice · 2008
- [KPV reduced white blood cell buildup in mice with peritonitis](https://pepvault.app/research/kpv-getting-2003) Animal study · mice · 2003
- [AOD-9604 knee injections lowered cartilage damage in rabbits](https://pepvault.app/research/aod-9604-kwon-2015) Animal study · rabbits · 2015
- [AOD-9604 lowered body weight and body fat in obese mice over 14 days](https://pepvault.app/research/aod-9604-heffernan-2001) Animal study · mice · 2001
- [AOD-9604 cut weight gain by over 50% in obese Zucker rats](https://pepvault.app/research/aod-9604-ng-2000) Animal study · obese Zucker rats · 2000
- [AOD-9604 reduced weight gain and fat tissue mass in obese mice](https://pepvault.app/research/aod-9604-natera-1994) Animal study · mice · 1994
- [Thymosin beta-4 in pregnant mice: longer newborns, more mature organs](https://pepvault.app/research/thymosin-beta-4-faa-2021) Animal study · mice · 2021
- [Thymosin beta-4 raised survival in mice with a coronavirus infection](https://pepvault.app/research/thymosin-beta-4-yu-2021) Animal study · mice · 2021
- [Thymosin beta-4: more liver fibrosis in mice bred to make extra TB4](https://pepvault.app/research/thymosin-beta-4-kim-2017) Animal study · mice · 2017
- [Thymosin Beta-4 sped full thickness skin wound healing in rats](https://pepvault.app/research/thymosin-beta-4-malinda-1999) Animal study · rats · 1999
- [ARA-290 eased nerve-injury pain for up to 20 weeks in rats](https://pepvault.app/research/ara-290-swartjes-2014) Animal study · rats · 2014
- [Ac-SDKP taken by mouth eased kidney scarring in diabetic mice](https://pepvault.app/research/tb-500-fragment-nitta-2016) Animal study · mice · 2016
- [Ipamorelin reduced cisplatin weight loss by about 24% in ferrets](https://pepvault.app/research/ipamorelin-lu-2024) Animal study · ferrets · 2024
- [Ipamorelin sped gastric emptying after abdominal surgery in rats](https://pepvault.app/research/ipamorelin-greenwood-van-meerveld-2012) Animal study · rats · 2012
- [Ipamorelin sped first bowel movement after gut surgery in rats](https://pepvault.app/research/ipamorelin-venkova-2009) Animal study · rats · 2009
- [Ipamorelin for 21 days raised pituitary secretion granules in rats](https://pepvault.app/research/ipamorelin-jimenez-reina-2002) Animal study · rats · 2002
- [Ipamorelin offset glucocorticoid-linked bone formation drop in rats](https://pepvault.app/research/ipamorelin-andersen-2001) Animal study · rats · 2001
- [Ipamorelin raised bone mineral content in female rats over 12 weeks](https://pepvault.app/research/ipamorelin-svensson-2000) Animal study · rats · 2000
- [Ipamorelin: new derivative matched its GH potency in swine](https://pepvault.app/research/ipamorelin-ankersen-1998) Animal study · rats, swine and dogs · 1998
- [Ipamorelin: about 20% nasal bioavailability in rats](https://pepvault.app/research/ipamorelin-johansen-1998) Animal study · rats · 1998
- [Ipamorelin released GH without raising ACTH or cortisol in swine](https://pepvault.app/research/ipamorelin-raun-1998) Animal study · rats and swine · 1998
- [CJC-1295 with DAC daily normalized growth in GHRH knockout mice](https://pepvault.app/research/cjc-1295-with-dac-alba-2006) Animal study · mice · 2006
- [CJC-1295 with DAC: 4-fold larger GH response than hGRF(1-29) in rats](https://pepvault.app/research/cjc-1295-with-dac-jette-2005) Animal study · rats · 2005
- [Hexarelin protected rat hearts from ischemia-reperfusion damage](https://pepvault.app/research/hexarelin-locatelli-1999) Animal study · rats · 1999
- [Hexarelin kept its growth hormone effect over 60 days in old rats](https://pepvault.app/research/hexarelin-cattaneo-1997) Animal study · rats · 1997
- [IGF-1 LR3 lowered blood sugar longer than native IGF-I in pigs](https://pepvault.app/research/igf-1-lr3-tomas-1997) Animal study · pigs and marmoset monkeys · 1997
- [IGF-1 LR3 raised organ weights but not growth in guinea pigs](https://pepvault.app/research/igf-1-lr3-conlon-1995) Animal study · guinea pigs · 1995
- [IGF-1 LR3: several times as potent as IGF-I for gut growth in rats](https://pepvault.app/research/igf-1-lr3-read-1992) Animal study · rats · 1992
- [IGF-1 LR3: about 2.5-fold more potent than IGF-I in catabolic rats](https://pepvault.app/research/igf-1-lr3-tomas-1992) Animal study · rats · 1992
- [PEG-MGF: heart function preserved after heart attack in mice](https://pepvault.app/research/peg-mgf-mavrommatis-2013) Animal study · mice · 2013
- [Retatrutide cut body weight by 31% in obese mice with MASH](https://pepvault.app/research/retatrutide-briand-2026) Animal study · mice and hamsters · 2026
- [Retatrutide: 24.1% weight loss in MC4R-deficient mice over 21 days](https://pepvault.app/research/retatrutide-hitaka-2026) Animal study · mice · 2026
- [Retatrutide: 14-fold smaller pancreatic tumors in mice](https://pepvault.app/research/retatrutide-marathe-2025) Animal study · mice · 2025
- [Retatrutide eased diet-induced steatohepatitis in female mice](https://pepvault.app/research/retatrutide-viebahn-2025) Animal study · mice · 2025
- [Pemvidutide cut body weight about 25% in mice with NASH](https://pepvault.app/research/pemvidutide-nestor-2022) Animal study · mice · 2022
- [5-Amino-1MQ slowed bladder tumor growth in mice](https://pepvault.app/research/5-amino-1mq-yang-2024) Animal study · mice · 2024
- [5-Amino-1MQ plus low-fat diet gave obese mice a distinct microbiome](https://pepvault.app/research/5-amino-1mq-dimet-wiley-2022) Animal study · mice · 2022
- [SLU-PP-332 cut fat mass and improved insulin sensitivity in obese mice](https://pepvault.app/research/slu-pp-332-billon-2024) Animal study · mice · 2024
- [SLU-PP-332 improved ejection fraction and survival in mice](https://pepvault.app/research/slu-pp-332-xu-2024) Animal study · mice · 2024
- [SLU-PP-332 increased exercise endurance in mice](https://pepvault.app/research/slu-pp-332-billon-2023) Animal study · mice · 2023
- [SLU-PP-332 reversed age-related kidney changes in old mice](https://pepvault.app/research/slu-pp-332-wang-2023) Animal study · mice · 2023
- [Oxytocin in mice: 10ng/h raised anxiety; 1ng/h averted stress anxiety](https://pepvault.app/research/oxytocin-peters-2014) Animal study · mice · 2014
- [MOTS-c reduced islet cell senescence and glucose intolerance in mice](https://pepvault.app/research/mots-c-kong-2025) Animal study · mice · 2025
- [MOTS-c eased lung ischemia-reperfusion injury and deaths in rats](https://pepvault.app/research/mots-c-li-2025) Animal study · rats · 2025
- [MOTS-c improved heart mitochondrial respiration in diabetic rats](https://pepvault.app/research/mots-c-pham-2025) Animal study · rats · 2025
- [MOTS-c prevented muscle atrophy, raised muscle glucose uptake in mice](https://pepvault.app/research/mots-c-kumagai-2024) Animal study · mice · 2024
- [MOTS-c raised testosterone, LH and FSH in obese and non-obese rats](https://pepvault.app/research/mots-c-ozturk-ozturk-2024) Animal study · rats · 2024
- [MOTS-c improved heart small-vessel barrier under endotoxin in mice](https://pepvault.app/research/mots-c-zou-2024) Animal study · mice · 2024
- [MOTS-c eased high blood sugar in mice with gestational diabetes](https://pepvault.app/research/mots-c-yin-2022) Animal study · mice · 2022
- [FOXO4-DRI improved sperm quality in naturally aged mice](https://pepvault.app/research/foxo4-dri-li-2024) Animal study · mice · 2024
- [FOXO4-DRI eased age-related testosterone shortfall in aged mice](https://pepvault.app/research/foxo4-dri-zhang-2020) Animal study · mice · 2020
- [SS-31 aided functional recovery after spinal cord injury in mice](https://pepvault.app/research/ss-31-zhang-2023) Animal study · mice · 2023
- [SS-31 partly undid age-related muscle phosphorylation in old mice](https://pepvault.app/research/ss-31-campbell-2022) Animal study · mice · 2022
- [SS-31 eased LPS-induced learning and memory problems in mice](https://pepvault.app/research/ss-31-zhao-2019) Animal study · mice · 2019
- [Pinealon improved learning in offspring of rats fed extra methionine](https://pepvault.app/research/pinealon-arutjunyan-2012) Animal study · rats · 2012
- [Vesugen (KED) prevented dendritic spine loss in Alzheimer's mice](https://pepvault.app/research/vesugen-khavinson-2021) Animal study · mice · 2021
- [Klotho: one low dose enhanced memory in aged nonhuman primates](https://pepvault.app/research/klotho-castner-2023) Animal study · aged nonhuman primates · 2023
- [Klotho: higher levels improved learning and memory in mice](https://pepvault.app/research/klotho-dubal-2014) Animal study · mice · 2014
- [Dihexa plus stem cells improved rat motor function after nerve repair](https://pepvault.app/research/dihexa-weiss-2021) Animal study · rats · 2021
- [Dihexa showed antidementia activity in scopolamine and aged rat models](https://pepvault.app/research/dihexa-mccoy-2013) Animal study · rats · 2013
- [Selank and GABA changed expression of 45 rat brain genes at 1 hour](https://pepvault.app/research/selank-volkova-2016) Animal study · rats · 2016
- [Semax shifted BDNF and NGF gene activity in rat brain within 1 hour](https://pepvault.app/research/semax-agapova-2007) Animal study · rats · 2007
- [Semax raised hippocampal BDNF levels up to 1.4-fold in rats](https://pepvault.app/research/semax-dolotov-2006) Animal study · rats · 2006
- [Semax raised striatal 5-HIAA to 180% in rodents](https://pepvault.app/research/semax-eremin-2005) Animal study · rodents · 2005
- [NSI-189 eased nerve damage and memory problems in diabetic rats](https://pepvault.app/research/nsi-189-jolivalt-2022) Animal study · rats · 2022
- [NSI-189 protected nerves and memory in diabetic mice](https://pepvault.app/research/nsi-189-jolivalt-2019) Animal study · mice · 2019
- [NSI-189 eased motor and neurological deficits after stroke in rats](https://pepvault.app/research/nsi-189-tajiri-2017) Animal study · rats · 2017
- [P21: lowered tau in the brain and spinal fluid of aged rats](https://pepvault.app/research/p21-khatoon-2015) Animal study · rats · 2015
- [P21 reduced tau buildup and cognitive deficits in Alzheimer's mice](https://pepvault.app/research/p21-kazim-2014) Animal study · mice · 2014

By kind

## Cell study

- [BPC-157 sped tendon cell outgrowth and migration in rat cells](https://pepvault.app/research/bpc-157-chang-2011) Cell study · rat Achilles tendon fibroblasts · 2011
- [GHK-Cu plus hyaluronic acid raised collagen IV in human fibroblasts](https://pepvault.app/research/ghk-cu-jiang-2023) Cell study · human dermal fibroblasts · 2023
- [GHK-Cu raised osteoblastic cell attachment in rat and human cells](https://pepvault.app/research/ghk-cu-godet-1995) Cell study · rat calvaria cells, human trabecular osteoblastic cells and human marrow stromal cells · 1995
- [GHK-Cu boosted growth of chick embryo cartilage cells in culture](https://pepvault.app/research/ghk-cu-pesakova-1995) Cell study · chick embryo chondrocytes · 1995
- [Thymosin beta-4 rescued AD-linked defects in human brain organoids](https://pepvault.app/research/thymosin-beta-4-zeng-2025) Cell study · human brain organoids · 2025
- [Thymosin beta-4 cut prion-driven leak in human brain endothelial cells](https://pepvault.app/research/thymosin-beta-4-song-2020) Cell study · hCMEC/D3 human cerebral endothelial cells · 2020
- [LL-37 drove IL-1β and IL-18 release from human and murine macrophages](https://pepvault.app/research/ll-37-kahlenberg-2013) Cell study · human and murine macrophages · 2013
- [LL-37 raised TLR9 and interferon output in human skin cells](https://pepvault.app/research/ll-37-morizane-2012) Cell study · normal human keratinocytes · 2012
- [Fragment 176-191 aided doxorubicin against MCF-7 breast cancer cells](https://pepvault.app/research/fragment-176-191-habibullah-2022) Cell study · human MCF-7 breast cancer cells · 2022
- [PEG-MGF (MGF): no rise in mouse or human muscle cell proliferation](https://pepvault.app/research/peg-mgf-fornaro-2014) Cell study · C2C12 cells, primary human skeletal muscle myoblasts, primary mouse skeletal muscle stem cells and cardiac myocytes · 2014
- [PEG-MGF extended division of human muscle cells from young donors](https://pepvault.app/research/peg-mgf-kandalla-2011) Cell study · human muscle cells · 2011
- [5-Amino-1MQ slowed growth of HeLa cervical cancer cells in the lab](https://pepvault.app/research/5-amino-1mq-akar-2021) Cell study · HeLa cervical cancer cells · 2021
- [MOTS-c lowered insulin, raised glucagon in pancreatic cell lines](https://pepvault.app/research/mots-c-bien-2024) Cell study · INS-1E and αTC-1 pancreatic cell lines · 2024
- [Epitalon restored wound healing in high-glucose human retinal cells](https://pepvault.app/research/epitalon-gatta-2025) Cell study · human retinal pigment epithelial cells (ARPE-19) · 2025
- [Epitalon lowered ROS and apoptosis in aging mouse oocytes in vitro](https://pepvault.app/research/epitalon-yue-2022) Cell study · mouse oocytes · 2022
- [Humanin inhibited IGFBP-3 cell death in human glioblastoma cells](https://pepvault.app/research/humanin-ikonen-2003) Cell study · human glioblastoma A172 cells and mouse cortical neurons · 2003
- [FOXO4-DRI raised cell death in lab-grown keloid fibroblasts](https://pepvault.app/research/foxo4-dri-kong-2025) Cell study · human keloid fibroblasts · 2025
- [FOXO4-DRI cleared senescent cells from expanded human chondrocytes](https://pepvault.app/research/foxo4-dri-huang-2021) Cell study · human chondrocytes · 2021
- [Pinealon lowered free radicals and cell death in PC12 and brain cells](https://pepvault.app/research/pinealon-khavinson-2011) Cell study · cerebellar granule cells, neutrophils and PC12 cells · 2011

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=research-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=research-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on PepVault

### On PepVault

- [The peptide library](https://pepvault.app/peptides)
- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The glossary](https://pepvault.app/glossary)
- [Guides](https://pepvault.app/guides)
- [Free tools](https://pepvault.app/tools)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

### How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [About PepVault](https://pepvault.app/about)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=research-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [How we research](https://pepvault.app/guides/how-we-research)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Reconstitution Lab (3D)](https://pepvault.app/lab)
- [Injection guide (3D)](https://pepvault.app/lab/injection)
- [Peptide Sky (3D)](https://pepvault.app/lab/sky)
- [Peptide tier list](https://pepvault.app/lab/tiers)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

## Choosing an app?

- [Compare peptide tracker apps](https://pepvault.app/best-peptide-tracker-apps)
- [Peptide vial tracker app](https://pepvault.app/peptide-vial-tracker-app)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
